Targeting EZH2 in cancer

被引：1189

作者：

Kim, Kimberly H. ^{[1
,2
,3
,4
,5
]}

Roberts, Charles W. M. ^{[1
,2
,3
,4
,5
,6
,7
]}

机构：

[1] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA

[2] Boston Childrens Hosp, Div Hematol Oncol, Boston, MA USA

[3] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA

[4] Broad Inst Harvard, Boston, MA USA

[5] MIT, Boston, MA USA

[6] St Jude Childrens Res Hosp, Ctr Comprehens Canc, 332 N Lauderdale St, Memphis, TN 38105 USA

[7] St Jude Childrens Res Hosp, Dept Oncol, 332 N Lauderdale St, Memphis, TN 38105 USA

来源：

NATURE MEDICINE | 2016年 / 22卷 / 02期

关键词：

POLYCOMB-REPRESSIVE COMPLEX; HISTONE METHYLTRANSFERASE EZH2; GROUP PROTEIN EZH2; EMBRYONIC STEM-CELLS; ACUTE LYMPHOBLASTIC-LEUKEMIA; CHROMATIN REMODELING GENES; NERVE SHEATH TUMORS; SOMATIC MUTATIONS; PROSTATE-CANCER; BREAST-CANCER;

D O I：

10.1038/nm.4036

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Recent genomic studies have resulted in an emerging understanding of the role of chromatin regulators in the development of cancer. EZH2, a histone methyl transferase subunit of a Polycomb repressor complex, is recurrently mutated in several forms of cancer and is highly expressed in numerous others. Notably, both gain-of-function and loss-of-function mutations occur in cancers but are associated with distinct cancer types. Here we review the spectrum of EZH2-associated mutations, discuss the mechanisms underlying EZH2 function, and synthesize a unifying perspective that the promotion of cancer arises from disruption of the role of EZH2 as a master regulator of transcription. We further discuss EZH2 inhibitors that are now showing early signs of promise in clinical trials and also additional strategies to combat roles of EZH2 in cancer.

引用

页码：128 / 134

页数：7

共 122 条

[41] Tobacco Smoke Induces Polycomb-Mediated Repression of Dickkopf-1 in Lung Cancer Cells [J].

Hussain, Mustafa ;

Rao, Mahadev ;

Humphries, Ashley E. ;

Hong, Julie A. ;

Liu, Fang ;

Yang, Maocheng ;

Caragacianu, Diana ;

Schrump, David S. .

CANCER RESEARCH, 2009, 69 (08) :3570-3578

[42] Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A [J].

Jankowska, Anna M. ;

Makishima, Hideki ;

Tiu, Ramon V. ;

Szpurka, Hadrian ;

Huang, Yun ;

Traina, Fabiola ;

Visconte, Valeria ;

Sugimoto, Yuka ;

Prince, Courtney ;

O'Keefe, Christine ;

Hsi, Eric D. ;

List, Alan ;

Sekeres, Mikkael A. ;

Rao, Anjana ;

McDevitt, Michael A. ;

Maciejewski, Jaroslaw P. .

BLOOD, 2011, 118 (14) :3932-3941

[43] Enhancer of zeste homolog 2 is involved in the proliferation of endometrial carcinoma [J].

Jia, Nan ;

Li, Qing ;

Tao, Xiang ;

Wang, Jieyu ;

Hua, Keqin ;

Feng, Weiwei .

ONCOLOGY LETTERS, 2014, 8 (05) :2049-2054

[44] Dissecting the genomic complexity underlying medulloblastoma [J].

Jones, David T. W. ;

Jaeger, Natalie ;

Kool, Marcel ;

Zichner, Thomas ;

Hutter, Barbara ;

Sultan, Marc ;

Cho, Yoon-Jae ;

Pugh, Trevor J. ;

Hovestadt, Volker ;

Stuetz, Adrian M. ;

Rausch, Tobias ;

Warnatz, Hans-Joerg ;

Ryzhova, Marina ;

Bender, Sebastian ;

Sturm, Dominik ;

Pleier, Sabrina ;

Cin, Huriye ;

Pfaff, Elke ;

Sieber, Laura ;

Wittmann, Andrea ;

Remke, Marc ;

Witt, Hendrik ;

Hutter, Sonja ;

Tzaridis, Theophilos ;

Weischenfeldt, Joachim ;

Raeder, Benjamin ;

Avci, Meryem ;

Amstislavskiy, Vyacheslav ;

Zapatka, Marc ;

Weber, Ursula D. ;

Wang, Qi ;

Lasitschka, Baerbel ;

Bartholomae, Cynthia C. ;

Schmidt, Manfred ;

von Kalle, Christof ;

Ast, Volker ;

Lawerenz, Chris ;

Eils, Juergen ;

Kabbe, Rolf ;

Benes, Vladimir ;

van Sluis, Peter ;

Koster, Jan ;

Volckmann, Richard ;

Shih, David ;

Betts, Matthew J. ;

Russell, Robert B. ;

Coco, Simona ;

Tonini, Gian Paolo ;

Schueller, Ulrich ;

Hans, Volkmar .

NATURE, 2012, 488 (7409) :100-105

[45] PAF and EZH2 Induce Wnt/β-Catenin Signaling Hyperactivation [J].

Jung, Hae-Yun ;

Jun, Sohee ;

Lee, Moonsup ;

Kim, Han-Cheon ;

Wang, Xin ;

Ji, Hong ;

McCrea, Pierre D. ;

Park, Jae-Il .

MOLECULAR CELL, 2013, 52 (02) :193-205

[46] Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy [J].

Kadoch, Cigall ;

Hargreaves, Diana C. ;

Hodges, Courtney ;

Elias, Laura ;

Ho, Lena ;

Ranish, Jeff ;

Crabtree, Gerald R. .

NATURE GENETICS, 2013, 45 (06) :592-+

[47] Polycomb Repressor Complex-2 Is a Novel Target for Mesothelioma Therapy [J].

Kemp, Clinton D. ;

Rao, Mahadev ;

Xi, Sichuan ;

Inchauste, Suzanne ;

Mani, Haresh ;

Fetsch, Patricia ;

Filie, Armando ;

Zhang, Mary ;

Hong, Julie A. ;

Walker, Robert L. ;

Zhu, Yuelin J. ;

Ripley, R. Taylor ;

Mathur, Aarti ;

Liu, Fang ;

Yang, Maocheng ;

Meltzer, Paul A. ;

Marquez, Victor E. ;

De Rienzo, Assunta ;

Bueno, Raphael ;

Schrump, David S. .

CLINICAL CANCER RESEARCH, 2012, 18 (01) :77-90

[48] SWI/SNF mediates polycomb eviction and epigenetic reprogramming of the INK4b-ARF-INK4a locus [J].

Kia, Sima Kheradmand ;

Gorski, Marcin M. ;

Giannakopoulos, Stavros ;

Verrijzer, C. Peter .

MOLECULAR AND CELLULAR BIOLOGY, 2008, 28 (10) :3457-3464

[49] Phosphorylation of EZH2 Activates STAT3 Signaling via STAT3 Methylation and Promotes Tumorigenicity of Glioblastoma Stem-like Cells [J].

Kim, Eunhee ;

Kim, Misuk ;

Woo, Dong-Hun ;

Shin, Yongjae ;

Shin, Jihye ;

Chang, Nakho ;

Oh, Young Taek ;

Kim, Hong ;

Rheey, Jingeun ;

Nakano, Ichiro ;

Lee, Cheolju ;

Joo, Kyeung Min ;

Rich, Jeremy N. ;

Nam, Do-Hyun ;

Lee, Jeongwu .

CANCER CELL, 2013, 23 (06) :839-852

[50] SWI/SNF-mutant cancers depend on catalytic and non-catalytic activity of EZH2 [J].

Kim, Kimberly H. ;

Kim, Woojin ;

Howard, Thomas P. ;

Vazquez, Francisca ;

Tsherniak, Aviad ;

Wu, Jennifer N. ;

Wang, Weishan ;

Haswell, Jeffrey R. ;

Walensky, Loren D. ;

Hahn, William C. ;

Orkin, Stuart H. ;

Roberts, Charles W. M. .

NATURE MEDICINE, 2015, 21 (12) :1491-+

← 1 2 3 4 5 6 7 8 9 10 →